Also known as Tavneos
Avacopan, sold under the brand name Tavneos, is a medication used to treat anti-neutrophil cytoplasmic autoantibody-associated vasculitis. Avacopan is a complement 5a receptor antagonist and a cytochrome P450 3A4 inhibitor.
~7 min read
{{Infobox drug | image = Avacopan structure.svg | image_class = skin-invert-image | width = 250px | alt = | caption =
| pronounce = | tradename = Tavneos | Drugs.com = | MedlinePlus = a622023 | DailyMedID = Avacopan | pregnancy_AU = D | pregnancy_AU_comment = | pregnancy_category= | routes_of_administration = By mouth | class = Complement C5a receptor antagonist | ATC_prefix = L04 | ATC_suffix = AJ05 | ATC_supplemental =
Discovered by embedding cosine similarity (sentence-transformers MiniLM, 384-dim).